Home > Food & Beverages > Nutraceuticals > Omega 3 > EPA/DHA (Omega 3) Ingredients Market

EPA/DHA (Omega 3) Ingredients Market Analysis

  • Report ID: GMI118
  • Published Date: Nov 2022
  • Report Format: PDF

EPA/DHA Ingredients Market Analysis

EPA/DHA (Omega 3) ingredients market share from DHA segment is estimated to exceed USD 4.5 billion by 2032. Docosahexaenoic acid (DHA) omega-3 fatty acids are used in infant foods owing to their ability to aid in the development of the brain, eyes, and nervous system. They are also considered to help prevent the risk of early preterm births. For instance, according to an NICHD-funded clinical trial in May 2021, pregnant women who consumed 1,000 mg/day of DHA showcased a relatively lower preterm birth rate as compared to those who took 200 mg/day. Increasing R&D on DHA benefits on maternal and infant health will complement the segment statistics.


Industry share from anchovy/sardine oils source is projected to witness over 8.5% CAGR between 2023-2032. Rise in the rate of mortality associated with heart disorders as a result of poor dietary habits and unhealthy lifestyles will fuel the consumption of anchovy and sardine oils as they are a rich source of omega-3 fatty acids including EPA and DHA. Anchovy oil helps lower blood pressure and reduce the risk of cardiovascular mortality. Cardiovascular diseases (CVDs) are a leading cause of death globally. According to the Centers for Disease Prevention & Control (CDC), one person dies every 34 seconds by CVD in the U.S.


Global EPA/DHA (Omega 3) Ingredients Market, by Application

EPA/DHA (Omega 3) ingredients market share from dietary supplements is anticipated to expand at more than 6.5% CAGR through 2032. Growing consumer inclination towards high-quality dietary supplements to strengthen immunity and reduce the impact of a hectic lifestyle will positively influence the industry statistics. Dietary supplements containing EPA and DHA offer a wide range of health benefits. According to a study conducted by Pharmavite, in 2021, more than 68% of adults and 95% of children in the U.S fail to consume the required amounts of omega-3s as per the U.S. Dietary Guidelines. Omega-3 deficiency has a negative impact on vision and heart health and increases the risk of inflammation, thus propelling the demand EPA & DHA-rich dietary supplements.


Global EPA DHA (Omega 3) Ingredients Market, By Region

Asia Pacific EPA/DHA (Omega 3) ingredients market size is poised to reach USD 1.5 billion by 2032. The presence of a constantly growing geriatric population suffering from age-related physical ailments will augment industry expansion. Omega-3 plays a significant nutritional role in maintaining heart health and brain health in the elderly population. Lack of EPA and DHA is linked with health conditions such as reduced immune function, memory loss, depression, Dementia, and a spectrum of other mental health problems. According to a study published in The Lancet Public Health, the number of people with dementia will surge by 197% in India, affecting nearly 152.8 million individuals by 2050. 

Authors: Kunal Ahuja, Sarita Bayas

Frequently Asked Questions (FAQ) :

Global market for EPA/DHA (Omega 3) ingredients was worth more than USD 2.5 billion in 2022 and is expected to record 6.5% CAGR from 2023-2032.

EPA/DHA (Omega 3) ingredients industry share from DHA segment is estimated to exceed USD 4.5 billion by 2032 due to its ability to prevent the risk of early preterm births.

Asia Pacific market size from EPA/DHA (Omega 3) ingredients is poised to reach USD 1.5 billion by the end of 2032 on account of the rising prevalence of mental health disorders such as dementia.

BASF SE, Clover Corporation, Omega Protein, Copeinca ASA, GC Rieber, Solutex, OLVEA, and Lysi are some of the leading manufacturers of EPA/DHA (Omega 3) ingredients worldwide.

EPA/DHA (Omega 3) Ingredients Market Scope

Buy Now

Premium Report Details

  • Base Year: 2022
  • Companies covered: 13
  • Tables & Figures: 418
  • Countries covered: 29
  • Pages: 344
 Download Free Sample